Correct Answer: B. Vulva
Extramammary Paget's disease (EMPD) is an intraepithelial adenocarcinoma arising from apocrine gland-bearing skin. The vulva is the most common site for EMPD because it has the highest concentration of apocrine glands in the genital region. The vulva contains modified apocrine sweat glands (Bartholin's glands and sweat glands of the labia), making it the ideal substrate for malignant transformation of apocrine epithelium. Histologically, EMPD presents as intraepithelial neoplasia with characteristic "Paget cells"—large, pale, mucin-producing cells with prominent nucleoli. Clinically, patients present with chronic vulvar pruritus, erythema, and scaling that mimics benign dermatitis, leading to delayed diagnosis. The vulva accounts for approximately 65–75% of all EMPD cases in the genital region. Unlike mammary Paget's disease (which is almost always associated with underlying ductal carcinoma), vulvar EMPD can be primary (intraepithelial) or secondary to underlying adenocarcinoma. Indian surgical practice follows the same epidemiological pattern, with vulvar EMPD being the predominant presentation in gynecological oncology units.
Why the other options are wrong
A. Vagina — The vagina is lined by stratified squamous epithelium and lacks apocrine glands, making it an extremely rare site for EMPD. Vaginal adenocarcinomas are typically mucinous or clear-cell types arising from Müllerian remnants, not from apocrine differentiation. This option exploits confusion between genital adenocarcinomas and apocrine-origin malignancies. C. Cervix — The cervix is lined by columnar epithelium and is the site of squamous cell carcinoma and adenocarcinoma (endocervical type), but not EMPD. Cervical malignancies arise from HPV-related transformation or endocervical glandular epithelium, not apocrine glands. EMPD requires apocrine gland-bearing skin, which the cervix lacks. D. Uterus — The uterus is lined by Müllerian epithelium and develops adenocarcinomas (endometrial, serous, clear-cell), not EMPD. The endometrium and myometrium lack apocrine glands entirely. This option confuses uterine adenocarcinomas with apocrine-origin neoplasms, a common NBE trap in gynecological oncology.
High-Yield Facts
- Vulva is the most common site for extramammary Paget's disease (65–75% of genital EMPD cases) due to high concentration of apocrine glands.
- Paget cells are large, pale, mucin-positive cells with prominent nucleoli—diagnostic hallmark on histology (PAS+, mucicarmine+).
- Vulvar EMPD presents as chronic pruritus and erythema mimicking eczema or dermatitis, causing diagnostic delay of 1–2 years on average.
- Primary vulvar EMPD is intraepithelial (carcinoma in situ) in 70% of cases; secondary EMPD associated with underlying adenocarcinoma in 30%.
- Wide local excision with 5–10 mm margins is the standard surgical treatment; Mohs micrographic surgery preferred in specialized centers for margin assessment.
Mnemonics
EMPD Site Memory: AVCU A=Axilla, V=Vulva, C=Circumanal, U=Umbilicus. Vulva is the most common genital site. Use when recalling all EMPD locations. Why Vulva? APO-crine APOcrine glands → Vulva (Bartholin's, sweat glands). Vagina/Cervix/Uterus = no apocrine glands = no EMPD. Quick discriminator.
NBE Trap
NBE pairs "genital adenocarcinoma" with multiple female genital sites (vagina, cervix, uterus) to lure students who confuse adenocarcinoma histology with site-specific origin. The key discriminator is apocrine gland origin, not just adenocarcinoma morphology.
Clinical Pearl
In Indian gynecological oncology practice, vulvar EMPD is often misdiagnosed as chronic vulvitis or lichen sclerosus for months before biopsy. Any vulvar lesion with atypical features (asymmetry, failure to respond to topical steroids, age >50) warrants biopsy to exclude EMPD—early diagnosis significantly improves outcomes.
_Reference: Bailey & Love Ch. 74 (Vulval Disorders); Robbins Ch. 22 (Skin Neoplasms)_